Search

everythinglearnresearchcommunity

for

Search:↓

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

CMV infection increases the risk of GvHD after bone marrow transplants.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Skin issues can indicate immune system problems.

Entospletinib effectively prevents eye and skin GVHD in mice.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Transplant success has improved with better immunosuppressive drugs and donor matching.

Voriconazole can cause serious side effects, especially in long-term use.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.